Needham & Company upgraded Impax Laboratories (NASDAQ: IPXL) from Hold to Buy with a price target of $37.00 following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE